Volume 18 - Issue 9 - September, 2006
Case Report
08/01/2008
Farrukh Hussain, MD, FRCPC; John Ducas, MD; Tirath Gosal, MD
There are three classic techniques described for reimplantation of coronary arteries after repair of the ascending thoracic aorta.1–4 The original Bentall procedure was described in 1968 and is considered the standard technique .5 The Cabrol...
There are three classic techniques described for reimplantation of coronary arteries after repair of the ascending thoracic aorta.1–4 The original Bentall procedure was described in 1968 and is considered the standard technique .5 The Cabrol...
There are three classic...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Keshav R. Nayak, MD; Brian E. Jaski, MD
Fulminant myocarditis (FM) is an uncommon but potentially fatal condition characterized by widespread myocardial inflammation leading to severe decompensated heart failure.1 Rapidly progressive biventricular dysfunction or malignant...
Fulminant myocarditis (FM) is an uncommon but potentially fatal condition characterized by widespread myocardial inflammation leading to severe decompensated heart failure.1 Rapidly progressive biventricular dysfunction or malignant...
Fulminant myocarditis (FM) is an...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
John Ducas, MD; Farrukh Hussain, MD, FRCPC; Tirath Gosal, MD
**i*There are three classic techniques described for reimplantation of coronary arteries after repair of the ascending thoracic aorta.1–4 The original Bentall procedure was described in 1968 and is considered the standard technique.5 The...
**i*There are three classic techniques described for reimplantation of coronary arteries after repair of the ascending thoracic aorta.1–4 The original Bentall procedure was described in 1968 and is considered the standard technique.5 The...
**i*There are three classic...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Robert S. Dieter, MD, RVT; Aravinda Nanjundappa, MD, RVT, MBA
The first percutaneous transluminal coronary angioplasty (PTCA) in humans was performed by Dr. Andreas Gruentzig in 1974.1 Since then, major evolutions in PTCA have resulted in over 1,000 angioplasty procedures in the registry by 1980. The...
The first percutaneous transluminal coronary angioplasty (PTCA) in humans was performed by Dr. Andreas Gruentzig in 1974.1 Since then, major evolutions in PTCA have resulted in over 1,000 angioplasty procedures in the registry by 1980. The...
The first percutaneous...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
David Lasorda, MD, DO; Robert Maholic, DO
Patent foramen ovale (PFO) is a frequent, but relatively insignificant, clinical finding. An estimated 20–30% of the population may have the anomaly. The majority of PFOs are not associated with clinical or physiologic events.
Recently, PFOs...
Patent foramen ovale (PFO) is a frequent, but relatively insignificant, clinical finding. An estimated 20–30% of the population may have the anomaly. The majority of PFOs are not associated with clinical or physiologic events.
Recently, PFOs...
Patent foramen ovale (PFO) is a...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
Dmitriy N. Feldman, MD; Nichole Polin, MD; Srihari S. Naidu, MD
Case Presentation. A 39-year-old female with chronic hypertension presented with a 1-year history of progressive dyspnea. Echocardiography 6 months prior to admission confirmed hypertrophic obstructive cardiomyopathy (HOCM), and high-dose...
Case Presentation. A 39-year-old female with chronic hypertension presented with a 1-year history of progressive dyspnea. Echocardiography 6 months prior to admission confirmed hypertrophic obstructive cardiomyopathy (HOCM), and high-dose...
Case Presentation. A 39-year-old...
08/01/2008
Journal of Invasive Cardiology
Letters to the Editor
08/01/2008
Robert S. Dieter, MD, RVT; Sarfraz Sidhu, MD; Pat Mannebach, MD
Dear Editor,
We read with great interest the report by Mejia et al entitled “Left Main Coronary Embolism” in the June 2006 issue of the Journal of Invasive Cardiology. We had a similar case of an acute myocardial infarction secondary to left...
Dear Editor,
We read with great interest the report by Mejia et al entitled “Left Main Coronary Embolism” in the June 2006 issue of the Journal of Invasive Cardiology. We had a similar case of an acute myocardial infarction secondary to left...
Dear Editor,
We read with great...
08/01/2008
Journal of Invasive Cardiology
Letters to the Editor
08/01/2008
Raoul Bonan, MD
Is There a Need for a Technology that Will Promote
Positive Remodeling and Mild Plaque Increase?
“Favorable vessel remodeling observed in this study is consistent with the result of the previous gamma radiation study noted above,1 as well...
Is There a Need for a Technology that Will Promote
Positive Remodeling and Mild Plaque Increase?
“Favorable vessel remodeling observed in this study is consistent with the result of the previous gamma radiation study noted above,1 as well...
Is There a Need for a Technology...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
William J. van Gaal, III, MD, MBBS, FRACP; Adrian P. Banning, MD, PhD, MBBS; Jayanth R. Arnold, MD
Compared with bare metal stents (BMS), drug-eluting stents (DES) significantly reduce the risk of restenosis and the subsequent need for revascularization.1 Stent thrombosis remains a serious complication with either BMS or DES, with an...
Compared with bare metal stents (BMS), drug-eluting stents (DES) significantly reduce the risk of restenosis and the subsequent need for revascularization.1 Stent thrombosis remains a serious complication with either BMS or DES, with an...
Compared with bare metal stents...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Roque B. Arteaga, MD; Jonathan Tronolone, MD; Mahendra Mandawat, MBBS, MD
Coronary arteries originating from a single coronary ostium (CO) in the aorta, in the absence of congenital heart disease (CHD), are rare.1 In several large series, the incidence ranged from 0.024% to 0.066%.2–4 In 1979, Lipton et al proposed...
Coronary arteries originating from a single coronary ostium (CO) in the aorta, in the absence of congenital heart disease (CHD), are rare.1 In several large series, the incidence ranged from 0.024% to 0.066%.2–4 In 1979, Lipton et al proposed...
Coronary arteries originating...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Raul G. Bretal, MD; Pablo Pedroni, MD; Federico Giachello, MD
Case Report. A 51-year-old male was referred to our center because a fractured 9 Fr sheath, 7 cm long, inserted in the right vena jugularis interna migrated to the right ventricle. Both ends of the broken sheath impinged against the tricuspid...
Case Report. A 51-year-old male was referred to our center because a fractured 9 Fr sheath, 7 cm long, inserted in the right vena jugularis interna migrated to the right ventricle. Both ends of the broken sheath impinged against the tricuspid...
Case Report. A 51-year-old male...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Paul C. Ho, MD, MSc; Stephen Lam Chan, MD; Cyril Leung, MD
Reported success rates of percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) range from approximately 60–75%,1–3 and are much lower when compared with PCI of nontotal occlusions.4,5 When combined with specialized...
Reported success rates of percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) range from approximately 60–75%,1–3 and are much lower when compared with PCI of nontotal occlusions.4,5 When combined with specialized...
Reported success rates of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Takahiko Suzuki, MD; Yoshifumi Kashima, MD; Yoshihisa Kinoshita, MD
Drug-eluting stent (DES) implantation has been shown to considerably reduce the occurrence of restenosis compared to other modalities of percutaneous coronary intervention (PCI) such as plain old balloon angioplasty (POBA), bare metal stent...
Drug-eluting stent (DES) implantation has been shown to considerably reduce the occurrence of restenosis compared to other modalities of percutaneous coronary intervention (PCI) such as plain old balloon angioplasty (POBA), bare metal stent...
Drug-eluting stent (DES)...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI; Anthony A. Bavry, MD, MPH
Urgent coronary reperfusion unequivocally saves lives in the setting of acute coronary syndromes, however for most patients, the goal of percutaneous coronary intervention remains the control of anginal symptoms.1,2 As a standalone procedure,...
Urgent coronary reperfusion unequivocally saves lives in the setting of acute coronary syndromes, however for most patients, the goal of percutaneous coronary intervention remains the control of anginal symptoms.1,2 As a standalone procedure,...
Urgent coronary reperfusion...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Khaled M. Ziada, MD; David J. Moliterno, MD; Richard Charnigo, MD; J. Darrell Sneed, MD; David C. Booth, MD; Debabrata Mukherjee, MD, MS; Pranab Das, MD; Steven R. Steinhubl, MD
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Luis Gruberg, MD; Rafael Beyar, MD, DSc, MPH
Cardiovascular disease is the main cause of death at all stages of chronic renal failure and end-stage renal disease on hemodialysis (ESRD) in adults; it accounts for almost 50% of the mortality of these patients, with an annual mortality...
Cardiovascular disease is the main cause of death at all stages of chronic renal failure and end-stage renal disease on hemodialysis (ESRD) in adults; it accounts for almost 50% of the mortality of these patients, with an annual mortality...
Cardiovascular disease is the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Mathew Anil, MD; Rajpal K. Abhaichand, MD; K.A. Sambasivam, MD; P.R. Vydianathan, MD; P. Raveendran, MD; M. Saigopalan, MD; Sundar Gomathi
The percutaneous radial artery approach for coronary angiography (CAG) was first reported in 1989–19991 and subsequently transradial coronary angioplasty was reported in 1995 by Kiemeneij et al.2 The advantages of the radial artery approach...
The percutaneous radial artery approach for coronary angiography (CAG) was first reported in 1989–19991 and subsequently transradial coronary angioplasty was reported in 1995 by Kiemeneij et al.2 The advantages of the radial artery approach...
The percutaneous radial artery...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Kamal Chitkara, MRCP; Kai Hogrefe, MD; Neil Swanson, MD; Anthony H. Gershlick, MD, FRCP, MB, BS , BSc; Mariuca Vasa-Nicotera, MD
Coronary stent placement is the most commonly employed technique for percutaneous treatment of atherosclerotic heart disease. It accounts for about 75% of the procedures performed worldwide.1 In comparison to conventional balloon angioplasty,...
Coronary stent placement is the most commonly employed technique for percutaneous treatment of atherosclerotic heart disease. It accounts for about 75% of the procedures performed worldwide.1 In comparison to conventional balloon angioplasty,...
Coronary stent placement is the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Felix Buddeberg, MD; Jeffrey A. Hubbell, PhD; Bernhard Meier, MD, FACC, FESC; Donald L. Elbert, PhD; Stephan Windecker, MD; Daniel Mettler, DVM; Thomas Schaffner, MD; Michael Billinger, MD; Otto M. Hess, MD, PhD
Attempts to reduce neointimal proliferation following coronary artery stent implantation have focused on stent coatings with or without local drug delivery. Polymers provide some unique features, which determine their use as coating material:...
Attempts to reduce neointimal proliferation following coronary artery stent implantation have focused on stent coatings with or without local drug delivery. Polymers provide some unique features, which determine their use as coating material:...
Attempts to reduce neointimal...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Shahid Aziz, BSc, MD, MRCP, MBChB; David R. Ramsdale, FRCP, MD, BSc, MBChB
Ideally, cardiologists would like a stent that is easy to deliver, causes no acute thrombosis, provides insignificant late loss due to intimal hyperplasia and offers no risk of late thrombosis should antiplatelet therapy have to be withdrawn....
Ideally, cardiologists would like a stent that is easy to deliver, causes no acute thrombosis, provides insignificant late loss due to intimal hyperplasia and offers no risk of late thrombosis should antiplatelet therapy have to be withdrawn....
Ideally, cardiologists would...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
David E. Kandzari, MD; Sunil V. Rao, MD, FACC, FSCAI; Emily Honeycutt, MD
Treatment with drug-eluting stents (DES) has revolutionized percutaneous coronary intervention (PCI) due to their substantial efficacy in reducing restenosis and the need for repeat revascularization procedures. Despite this benefit, the...
Treatment with drug-eluting stents (DES) has revolutionized percutaneous coronary intervention (PCI) due to their substantial efficacy in reducing restenosis and the need for repeat revascularization procedures. Despite this benefit, the...
Treatment with drug-eluting...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Robert H. Tuttle, MSPH; James G. Jollis; David E. Kandzari, MD; James P. Zidar, MD
Randomized clinical trials evaluating coronary stents versus balloon angioplasty have demonstrated marked improvements in the short- and long-term safety and efficacy of percutaneous coronary intervention (PCI) by reducing restenosis and the...
Randomized clinical trials evaluating coronary stents versus balloon angioplasty have demonstrated marked improvements in the short- and long-term safety and efficacy of percutaneous coronary intervention (PCI) by reducing restenosis and the...
Randomized clinical trials...
08/01/2008
Journal of Invasive Cardiology
